SEC Form 4 · accession 0001645627-18-000038
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 16, 2018
Accepted (ET)
Jul 20, 2018 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 16, 2018 | P | 1,000 | $0.0346 | A | 25,183,289 | D | |
| Common Stock | Jul 16, 2018 | P | 1,009 | $0.0347 | A | 25,184,298 | D | |
| Common Stock | Jul 16, 2018 | P | 1,000 | $0.0347 | A | 25,185,298 | D | |
| Common Stock | Jul 16, 2018 | P | 1,000 | $0.0346 | A | 25,186,298 | D | |
| Common Stock | Jul 16, 2018 | P | 1,000 | $0.0362 | A | 25,187,298 | D | |
| Common Stock | Jul 16, 2018 | P | 1,000 | $0.0362 | A | 25,188,298 | D | |
| Common Stock | Jul 17, 2018 | P | 1,000 | $0.0358 | A | 25,189,298 | D | |
| Common Stock | Jul 17, 2018 | P | 1,000 | $0.0355 | A | 25,190,298 | D | |
| Common Stock | Jul 17, 2018 | P | 1,000 | $0.0355 | A | 25,191,298 | D | |
| Common Stock | Jul 18, 2018 | P | 1,000 | $0.0347 | A | 25,192,298 | D | |
| Common Stock | Jul 18, 2018 | P | 1,000 | $0.0343 | A | 25,193,298 | D | |
| Common Stock | Jul 18, 2018 | P | 2,000 | $0.0343 | A | 25,195,298 | D | |
| Common Stock | Jul 18, 2018 | P | 1,000 | $0.0343 | A | 25,196,298 | D | |
| Common Stock | Jul 18, 2018 | P | 1,000 | $0.0344 | A | 25,197,298 | D | |
| Common Stock | Jul 18, 2018 | P | 1,000 | $0.0344 | A | 25,198,298 | D | |
| Common Stock | Jul 18, 2018 | P | 1,000 | $0.0344 | A | 25,199,298 | D | |
| Common Stock | Jul 18, 2018 | P | 1,000 | $0.0344 | A | 25,200,298 | D |
Table II — derivative securities
No Table II lines on this filing.